Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Northeast Bank
NBN
$1.17B
| $1.44M | ﹤0.01% |
94,000
-18,200
| -16% | -$258K |
|
|
FLOW
2402
DELISTED
SPX FLOW, Inc.
FLOW
| $1.44M | ﹤0.01% |
+41,400
| New | +$1.41M |
|
2403
S&T Bancorp
STBA
$1.82B
| $1.44M | ﹤0.01% |
41,500
-67,600
| -62% | -$2.46M |
|
|
KTEC
2404
DELISTED
Key Technology Inc
KTEC
| $1.44M | ﹤0.01% |
108,289
+7,889
| +8% | +$101K |
|
2405
Sportsman's Warehouse
SPWH
$47.2M
| $1.43M | ﹤0.01% |
299,463
+33,889
| +13% | +$211K |
|
2406
HealthEquity
HQY
$8.75B
| $1.43M | ﹤0.01% |
+33,600
| New | +$1.49M |
|
|
JMBA
2407
DELISTED
Jamba, Inc.
JMBA
| $1.43M | ﹤0.01% |
157,585
+115,125
| +271% | +$1.11M |
|
2408
Outfront Media
OUT
$5.31B
| $1.42M | ﹤0.01% |
54,456
-144,622
| -73% | -$3.78M |
|
2409
PAR Technology
PAR
$759M
| $1.42M | ﹤0.01% |
198,400
+12,100
| +6% | +$78.2K |
|
|
DRNA
2410
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.42M | ﹤0.01% |
418,500
+9,818
| +2% | +$27.6K |
|
2411
NLI Holdings
NL
$325M
| $1.42M | ﹤0.01% |
220,404
+50,804
| +30% | +$343K |
|
2412
Kodak
KODK
$986M
| $1.42M | ﹤0.01% |
123,248
+9,858
| +9% | +$135K |
|
2413
First Industrial Realty Trust
FR
$8.42B
| $1.41M | ﹤0.01% |
53,115
+44,715
| +532% | +$1.2M |
|
2414
Old National Bancorp
ONB
$10.3B
| $1.41M | ﹤0.01% |
+81,476
| New | +$1.46M |
|
2415
STAAR Surgical
STAA
$1.25B
| $1.41M | ﹤0.01% |
144,300
+22,600
| +19% | +$225K |
|
2416
Inseego
INSG
$77.8M
| $1.41M | ﹤0.01% |
67,440
-4,200
| -6% | -$115K |
|
|
VIAB
2417
DELISTED
Viacom Inc. Class B
VIAB
| $1.41M | ﹤0.01% |
30,200
-1,116,800
| -97% | -$47.1M |
|
|
LKSD
2418
DELISTED
LSC Communications, Inc.
LKSD
| $1.4M | ﹤0.01% |
+55,500
| New | +$1.45M |
|
|
HMNF
2419
DELISTED
HMN Financial Inc
HMNF
| $1.4M | ﹤0.01% |
77,300
+2,700
| +4% | +$48.8K |
|
2420
State Street Materials Select Sector SPDR ETF
XLB
$8.56B
| $1.39M | ﹤0.01% |
+53,200
| New | +$1.38M |
|
|
GAU
2421
Galiano Gold
GAU
$549M
| $1.39M | ﹤0.01% |
531,393
+309,093
| +139% | +$956K |
|
2422
Resources Connection
RGP
$145M
| $1.39M | ﹤0.01% |
82,800
-116,400
| -58% | -$1.97M |
|
2423
Columbus McKinnon
CMCO
$545M
| $1.38M | ﹤0.01% |
55,600
-3,900
| -7% | -$103K |
|
2424
Bruker
BRKR
$8.87B
| $1.38M | ﹤0.01% |
59,110
+30,500
| +107% | +$716K |
|
|
SIRE
2425
DELISTED
Sisecam Resources LP
SIRE
| $1.37M | ﹤0.01% |
47,935
-11,967
| -20% | -$354K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.